These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12688436)

  • 1. The Asheville Project: participants' perceptions of factors contributing to the success of a patient self-management diabetes program.
    Garrett DG; Martin LA
    J Am Pharm Assoc (Wash); 2003; 43(2):185-90. PubMed ID: 12688436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program.
    Cranor CW; Christensen DB
    J Am Pharm Assoc (Wash); 2003; 43(2):149-59. PubMed ID: 12688433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Asheville Project: factors associated with outcomes of a community pharmacy diabetes care program.
    Cranor CW; Christensen DB
    J Am Pharm Assoc (Wash); 2003; 43(2):160-72. PubMed ID: 12688434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.
    Cranor CW; Bunting BA; Christensen DB
    J Am Pharm Assoc (Wash); 2003; 43(2):173-84. PubMed ID: 12688435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program.
    Fera T; Bluml BM; Ellis WM; Schaller CW; Garrett DG
    J Am Pharm Assoc (2003); 2008; 48(2):181-190. PubMed ID: 18359731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hickory project: controlling healthcare costs and improving outcomes for diabetes using the asheville project model.
    Bunting BA; Lee G; Knowles G; Lee C; Allen P
    Am Health Drug Benefits; 2011 Sep; 4(6):343-50. PubMed ID: 25126361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma.
    Bunting BA; Cranor CW
    J Am Pharm Assoc (2003); 2006; 46(2):133-47. PubMed ID: 16602223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hickory Project builds on the Asheville Project--an example of community-based diabetes care management.
    Lee GC; Mick T; Lam T
    J Manag Care Pharm; 2007; 13(6):531-3. PubMed ID: 17672816
    [No Abstract]   [Full Text] [Related]  

  • 9. [Japanese Model of Asheville Project. Its Overview and Initiative].
    Furukawa A; Asada Y; Mori T; Inoue G; Atsuda K
    Yakugaku Zasshi; 2016; 136(2):251-8. PubMed ID: 26831802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes Ten City Challenge: final economic and clinical results.
    Fera T; Bluml BM; Ellis WM
    J Am Pharm Assoc (2003); 2009; 49(3):383-91. PubMed ID: 19357068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication therapy management and condition care services in a community-based employer setting.
    Johannigman MJ; Leifheit M; Bellman N; Pierce T; Marriott A; Bishop C
    Am J Health Syst Pharm; 2010 Aug; 67(16):1362-7. PubMed ID: 20689127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOTx. MED: Pharmacist-delivered interventions to improve care for patients with diabetes.
    American Pharmacists Association
    J Am Pharm Assoc (2003); 2012; 52(1):25-33. PubMed ID: 22173068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.
    Bunting BA; Smith BH; Sutherland SE
    J Am Pharm Assoc (2003); 2008; 48(1):23-31. PubMed ID: 18192127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of community pharmacy-provided diabetes services to aid physicians in the National Committee for Quality Assurance recognition program.
    Brittain KL; Kuhn CH
    J Am Pharm Assoc (2003); 2009; 49(2):209-11. PubMed ID: 19289347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes.
    Garrett DG; Bluml BM
    J Am Pharm Assoc (2003); 2005; 45(2):130-7. PubMed ID: 15868754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative study exploring community pharmacists' awareness of, and contribution to, self-care support in the management of long-term conditions in the United Kingdom.
    Ogunbayo OJ; Schafheutle EI; Cutts C; Noyce PR
    Res Social Adm Pharm; 2015; 11(6):859-79. PubMed ID: 25677228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asheville Project improves patient outcomes, cuts medical costs.
    Young D
    Am J Health Syst Pharm; 2003 May; 60(9):868, 871. PubMed ID: 12756938
    [No Abstract]   [Full Text] [Related]  

  • 19. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to facilitate the implementation of collaborative practice agreements in chain community pharmacies.
    Bacci JL; Coley KC; McGrath K; Abraham O; Adams AJ; McGivney MS
    J Am Pharm Assoc (2003); 2016; 56(3):257-265.e2. PubMed ID: 27053276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.